1.The effect of antenatal dexamethasone administration on the prevention of RDS in preterm delivery.
Jae Sung CHO ; Yoon Tae LEE ; Yong Won PARK ; Chan Ho SONG ; Ran NAMGUNG
Korean Journal of Obstetrics and Gynecology 1992;35(10):1483-1488
No abstract available.
Dexamethasone*
2.Effects of dexamethasone on salivary function following irradiation.
Hoon Sang CHANG ; Won Pyo HONG ; Gyu Jong CHO ; Young Chan KIM ; Ho Ki LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(5):968-977
No abstract available.
Dexamethasone*
3.The Effects of Prenatal Dexamethasone Therapy for the Prevention of Respiratory Distress Syndrome of Premature Baby and Their Prognosis.
Sang Wook LEE ; Jong Woo HONG ; Yoon Seok YUM ; Kyu Seop JIN ; Seon Kyung LEE ; Chu Yeop HUH ; Seung Bo KIM
Korean Journal of Perinatology 2000;11(2):204-212
No abstract available.
Dexamethasone*
;
Prognosis*
4.Maternal and neonatal outcomes after multiple administration of dexamethasone to patients with preterm premature rupture of membranes.
Tae Joong KIM ; Woo Youg KIM ; Jin Kyung YOU ; Jong Dae WHANG ; Soon Ha YANG ; Je Ho LEE ; Cheong Rae ROH
Korean Journal of Obstetrics and Gynecology 2000;43(9):1646-1651
No abstract available.
Dexamethasone*
;
Humans
;
Membranes*
;
Rupture*
5.Management of Anterior Chamber Migration of Dexamethasone Intravitreal Implant.
Jun Young HA ; Jae Yong JANG ; Yong Sok JI
Korean Journal of Ophthalmology 2017;31(6):574-575
No abstract available.
Anterior Chamber*
;
Dexamethasone*
6.A Comparative Randomized Trial on the Optimal Timing of Dexamethasone for Pain Relief after Endoscopic Submucosal Dissection for Early Gastric Neoplasm.
Jeung Hui PYO ; Hyuk LEE ; Yang Won MIN ; Byung Hoon MIN ; Jun Haeng LEE ; Poong Lyul RHEE ; Jae J KIM
Gut and Liver 2016;10(4):549-555
BACKGROUND/AIMS: The aim of this study was to compare the clinical effects of preoperative and postoperative dexamethasone on pain after endoscopic submucosal dissection (ESD) for early gastric neoplasm. METHODS: Forty patients with early gastric neoplasm who were scheduled for ESD were randomized into two groups according to the timing of steroid administration: preoperative ("pre", n=20) and postoperative ("post", n=20) steroid administration. The pre group received 0.15 mg/kg dexamethasone before ESD and placebo after, and the post group received pre-ESD placebo and post-ESD dexamethasone. The present pain intensity (PPI) index and the short-form McGill pain (SF-MP) questionnaire were evaluated. RESULTS: The primary outcome was PPI score at 6 hours after ESD. There was a greater reduction in 6-hour PPI in the pre group than in the post group (2.1±0.8 vs 3.0±1.1, respectively; p=0.006). The immediate PPI was also significantly lower in the pre group than in the post group (1.6±0.6 vs 2.9±0.6, respectively; p<0.001), and the total SF-MP scores were significantly lower in the pre group than in the post group both immediately and at 6 hours after the operation. CONCLUSIONS: Preoperative administration of dexamethasone may produce a superior analgesic effect in patients who undergo ESD compared with the postoperative administration of dexamethasone.
Dexamethasone*
;
Humans
;
Stomach Neoplasms*
7.The comparisons of dexamethasone suppression test, brain computerized tomography, and clinical symptomatology in psychotic and non-psycotic depression.
Kheun Soo WANG ; Young Ho LEE ; Hong Bai EUN
Journal of Korean Neuropsychiatric Association 1992;31(3):576-586
No abstract available.
Brain*
;
Depression*
;
Dexamethasone*
8.Electroencephalographic sleep findings and dexamethasone suppression test in major psychotic disorders.
Dong Woo KANG ; Kyu Hee HAHN ; Jin Wook SOHN
Journal of Korean Neuropsychiatric Association 1991;30(1):112-124
No abstract available.
Dexamethasone*
;
Psychotic Disorders*
9.Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant
Gwang Myeong NOH ; Ki Yup NAM ; Seung Uk LEE ; Sang Joon LEE
Korean Journal of Ophthalmology 2019;33(4):392-394
No abstract available.
Central Serous Chorioretinopathy
;
Dexamethasone
10.Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy and Skin abnormalities (POEMS) syndrome in a Filipino nurse returning to work following bortezomib treatment: A case report.
Nadine J. ENDAYA ; Raymond L. ROSALES
Journal of Medicine University of Santo Tomas 2022;6(2):1021-1026
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes) also known as Crow-Fukase syndrome or Takatsuki syndrome is a rare and disabling paraneoplastic syndrome that frequently occurs in the fifth or sixth decade of life without a known standard first-line therapy. A 34-year-old Filipino male nurse, who presented with gradually progressive distal lower extremity weakness and sharp shooting pain in bilateral legs accompanied by mild joint effusion on the left knee, hypertrichosis, bilateral conjunctival injection, and gynecomastia underwent extensive workup and was diagnosed with POEMS syndrome. Complete blood count revealed erythrocytosis and thrombocytosis with elevated serum VEGF (vascular endothelial growth factor) and elevated monoclonal serum free lambda light chains. The electrophysiologic studies revealed chronic demyelinating sensorimotor polyneuropathy while bone marrow core biopsy and bone marrow aspirate smear immunohistochemical staining showed it to be positive for lambda and CD138. He had an initial unsuccessful treatment course with melphalan and prednisone. Hence, bortezomib and dexamethasone were given which gave significant improvement in symptoms from the overall neuropathy limitation score of 5 to 1.
Poems Syndrome|bortezomib|dexamethasone